151 related articles for article (PubMed ID: 7710936)
1. Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines.
Soncin M; Polo L; Reddi E; Jori G; Kenney ME; Cheng G; Rodgers MA
Br J Cancer; 1995 Apr; 71(4):727-32. PubMed ID: 7710936
[TBL] [Abstract][Full Text] [Related]
2. Effect of the delivery system on the biodistribution of Ge(IV) octabutoxy-phthalocyanines in tumour-bearing mice.
Soncin M; Polo L; Reddi E; Jori G; Kenney ME; Cheng G; Rodgers MA
Cancer Lett; 1995 Feb; 89(1):101-6. PubMed ID: 7882292
[TBL] [Abstract][Full Text] [Related]
3. Tumour-localising and -photosensitizing properties of liposome-delivered Ge(IV)-octabutoxy-phthalocyanine.
Cuomo V; Jori G; Rihter B; Kenney ME; Rodgers MA
Br J Cancer; 1991 Jul; 64(1):93-5. PubMed ID: 1854632
[No Abstract] [Full Text] [Related]
4. Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency.
Reddi E; Zhou C; Biolo R; Menegaldo E; Jori G
Br J Cancer; 1990 Mar; 61(3):407-11. PubMed ID: 2328207
[TBL] [Abstract][Full Text] [Related]
5. Tumour-localizing and tumour-photosensitizing properties of zinc(II)-octapentyl-phthalocyanine.
Fabris C; Ometto C; Milanesi C; Jori G; Cook MJ; Russell DA
J Photochem Photobiol B; 1997 Jul; 39(3):279-84. PubMed ID: 9253202
[TBL] [Abstract][Full Text] [Related]
6. CGP 55398, a liposomal Ge(IV) phthalocyanine bearing two axially ligated cholesterol moieties: a new potential agent for photodynamic therapy of tumours.
Segalla A; Milanesi C; Jori G; Capraro HG; Isele U; Schieweck K
Br J Cancer; 1994 May; 69(5):817-25. PubMed ID: 8180009
[TBL] [Abstract][Full Text] [Related]
7. Tumour-localising and -photosensitising properties of a novel zinc(II) octadecylphthalocyanine.
Ometto C; Fabris C; Milanesi C; Jori G; Cook MJ; Russell DA
Br J Cancer; 1996 Dec; 74(12):1891-9. PubMed ID: 8980387
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and phototherapeutic properties of axially substituted Si(IV)-tetradibenzobarreleno-octabutoxyphthalocyanines.
Soncin M; Busetti A; Reddi E; Jori G; Rither BD; Kenney ME; Rodgers MA
J Photochem Photobiol B; 1997 Sep; 40(2):163-7. PubMed ID: 9345784
[TBL] [Abstract][Full Text] [Related]
9. Effect of delivery system on the pharmacokinetic and phototherapeutic properties of bis(methyloxyethyleneoxy) silicon-phthalocyanine in tumor-bearing mice.
Wöhrle D; Muller S; Shopova M; Mantareva V; Spassova G; Vietri F; Ricchelli F; Jori G
J Photochem Photobiol B; 1999 Jun; 50(2-3):124-8. PubMed ID: 10515076
[TBL] [Abstract][Full Text] [Related]
10. Relative contributions of apoptosis and random necrosis in tumour response to photodynamic therapy: effect of the chemical structure of Zn(II)-phthalocyanines.
Jori G; Fabris C
J Photochem Photobiol B; 1998 Jun; 43(3):181-5. PubMed ID: 9718718
[TBL] [Abstract][Full Text] [Related]
11. Liposome-delivered Si(IV)-naphthalocyanine as a photodynamic sensitiser for experimental tumours: pharmacokinetic and phototherapeutic studies.
Cuomo V; Jori G; Rihter B; Kenney ME; Rodgers MA
Br J Cancer; 1990 Dec; 62(6):966-70. PubMed ID: 2257228
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetic and photodynamic studies with zinc(II) phthalocyanine in hamsters bearing an induced or transplanted rhabdomyosarcoma.
Shopova M; Mantareva V; Krastev K; Hadjiolov D; Milev A; Spirov K; Jori G; Ricchelli F
J Photochem Photobiol B; 1992 Oct; 16(1):83-9. PubMed ID: 1469513
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic studies with zinc(II)-phthalocyanine in tumour-bearing mice.
Reddi E; Lo Castro G; Biolo R; Jori G
Br J Cancer; 1987 Nov; 56(5):597-600. PubMed ID: 3426922
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy of tumours with hexadecafluoro zinc phthalocynine formulated in PEG-coated poly(lactic acid) nanoparticles.
Allémann E; Rousseau J; Brasseur N; Kudrevich SV; Lewis K; van Lier JE
Int J Cancer; 1996 Jun; 66(6):821-4. PubMed ID: 8647656
[TBL] [Abstract][Full Text] [Related]
15. Effects of photodynamic therapy on the absorption properties of disulphonated aluminum phthalocyanine in tumor-bearing mice.
Cubeddu R; Canti G; D'Andrea C; Pifferi A; Taroni P; Torricelli A; Valentini G
J Photochem Photobiol B; 2001 Jul; 60(2-3):73-8. PubMed ID: 11470561
[TBL] [Abstract][Full Text] [Related]
16. Liposome-delivered 131I-labelled Zn(II)-phthalocyanine as a radiodiagnostic agent for tumours.
Polo L; Segalla A; Jori G; Bocchiotti G; Verna G; Franceschini R; Mosca R; De Filippi PG
Cancer Lett; 1996 Dec; 109(1-2):57-61. PubMed ID: 9020903
[TBL] [Abstract][Full Text] [Related]
17. Tissue uptake, distribution, and potency of the photoactivatable dye chloroaluminum sulfonated phthalocyanine in mice bearing transplantable tumors.
Chan WS; Marshall JF; Lam GY; Hart IR
Cancer Res; 1988 Jun; 48(11):3040-4. PubMed ID: 3284641
[TBL] [Abstract][Full Text] [Related]
18. Hexadecafluorinated zinc phthalocyanine: photodynamic properties against the EMT-6 tumour in mice and pharmacokinetics using 65Zn as a radiotracer.
Boyle RW; Rousseau J; Kudrevich SV; Obochi M; van Lier JE
Br J Cancer; 1996 Jan; 73(1):49-53. PubMed ID: 8554982
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcoma.
Tralau CJ; MacRobert AJ; Coleridge-Smith PD; Barr H; Bown SG
Br J Cancer; 1987 Apr; 55(4):389-95. PubMed ID: 3580264
[TBL] [Abstract][Full Text] [Related]
20. Zn(II)-phthalocyanine as a photodynamic agent for tumours. II. Studies on the mechanism of photosensitised tumour necrosis.
Milanesi C; Zhou C; Biolo R; Jori G
Br J Cancer; 1990 Jun; 61(6):846-50. PubMed ID: 2372486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
